Then, it goes dormant in the nerves. If the immune system is weakened, it can come out again as shingles (herpes zoster), a ...

Most of us think shingles is an old person’s disease. But the reality is, it can strike at any time, triggered by ...

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

Expert Rev Vaccines. 2010;9(3s):21-26. While there is still no standard definition for PHN, for the purposes of this review it is defined as: clinically significant pain or painful abnormal ...

The incidence of herpes zoster was 5.4 cases vs. 11.1 cases per 1000 person-years in the vaccinated versus placebo groups, and the incidence of postherpetic neuralgia was 0.5 cases vs. 1.4 cases ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

This population-based study investigated the risk of having had prior herpes zoster within five years preceding a diagnosis of head and neck cancer. We conducted a case-control study that included ...

Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody ...

A recent study published in Alzheimer’s Research & Therapy examined the long-term subjective cognitive decline risk associated with Herpes zoster infections. It investigated whether the ...

2 SHINGRIX is approved for the prevention of shingles (herpes zoster) in adults aged 50 years and older. AREXVY is approved for the prevention of lower respiratory tract disease (LRTD) caused by ...

All of them were under the age of 50. Shingles, also called herpes zoster, is a viral infection caused by the reactivation of the virus that also causes chickenpox. The virus remains dormant in th ...